Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1304, 2001-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Intensive therapy beneficial in AA amyloidosis
Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. :
Eprodisate first in class for AA amyloidosis
Inpharma, Vol. 1, Iss. 1545, 2006-01 ,pp. :
Infliximab enhances methotrexate benefits in early RA
Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. :